The purpose of this study is to investigate how ketoconazole (Nizoral) affects the pharmacokinetics (how the study drug is affected by the body and broken down) and pharmacodynamics (how the study drug acts on the body) of the active ingredient in the study drug Velcade (bortezomib).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Medical Center, UPMC Cancer Pavilion
Pittsburgh, Pennsylvania, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.